National Engineering Research Center for Nanomedicine, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, 430074, China.
Key Laboratory of Molecular Biophysics of the Ministry of Education, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, 430074, China.
Nat Commun. 2022 May 19;13(1):2794. doi: 10.1038/s41467-022-30306-7.
Insufficient tumor accumulation and distribution of photosensitizers as well as low antitumor immunity severely restrict the therapeutic efficacy of photothermal therapy (PTT). Cancer-associated fibroblasts (CAFs) play a key role in tumor extracellular matrix (ECM) remodeling and immune evasion. Reshaping tumor microenvironment via CAF regulation might provide a potential approach for complete tumor elimination in combination with PTT. Here, tumor cell-derived microparticles co-delivering calcipotriol and Indocyanine green (Cal/ICG@MPs) are developed to modulate CAFs for improved PTT efficacy. Cal/ICG@MPs efficiently target tumor tissues and regulate CAFs to reduce tumor ECM, resulting in enhanced tumor accumulation and penetration of ICG to generate strong PTT efficacy and activate CD8 T cell-mediated antitumor immunity. In addition, Cal/ICG@MPs-triggered CAF regulation enhances tumor infiltration of CD8 T cells and ameliorates CAF-induced antigen-mediated activation-induced cell death of tumor-specific CD8 T cells in response to PTT, eliciting long-term antitumor immune memory to inhibit tumor recurrence and metastasis. Our results support Cal/ICG@MPs as a promising drug to improve PTT efficacy in cancer treatment.
由于肿瘤摄取和光敏剂分布不足以及抗肿瘤免疫低下,严重限制了光热治疗(PTT)的疗效。癌症相关成纤维细胞(CAFs)在肿瘤细胞外基质(ECM)重塑和免疫逃逸中发挥关键作用。通过 CAF 调控重塑肿瘤微环境,结合 PTT 可能为完全消除肿瘤提供一种潜在方法。在这里,开发了载有钙泊三醇和吲哚菁绿的肿瘤细胞衍生的微粒(Cal/ICG@MPs),以调节 CAFs 来提高 PTT 疗效。Cal/ICG@MPs 可有效靶向肿瘤组织并调节 CAFs 以减少肿瘤 ECM,从而增强 ICG 的肿瘤蓄积和渗透,产生强大的 PTT 疗效,并激活 CD8 T 细胞介导的抗肿瘤免疫。此外,Cal/ICG@MPs 触发的 CAF 调节增强了 CD8 T 细胞在肿瘤中的浸润,并改善了 CAF 诱导的抗原介导的对 PTT 反应的肿瘤特异性 CD8 T 细胞激活诱导的细胞死亡,引发长期抗肿瘤免疫记忆以抑制肿瘤复发和转移。我们的研究结果支持 Cal/ICG@MPs 作为一种有前途的药物,可提高癌症治疗中的 PTT 疗效。